LGMN and Alzheimer disease: Recently, we reported that AEP is activated in the brain in an age‐dependent manner and cleaves amyloid precursor protein (APP) and tau, promoting the deposition of amyloid‐β (Aβ) and tau during the onset of AD (Zhang et al., 2014, 2015).